0001140361-18-032716.txt : 20180717
0001140361-18-032716.hdr.sgml : 20180717
20180717162702
ACCESSION NUMBER: 0001140361-18-032716
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180713
FILED AS OF DATE: 20180717
DATE AS OF CHANGE: 20180717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAWLIS V BRYAN
CENTRAL INDEX KEY: 0001247681
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37722
FILM NUMBER: 18956752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc.
CENTRAL INDEX KEY: 0001636282
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464312787
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 901 S. MOPAC EXPRESSWAY, STE. 250
STREET 2: BARTON OAKS PLAZA ONE
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: (512) 942-2935
MAIL ADDRESS:
STREET 1: 901 S. MOPAC EXPRESSWAY, STE. 250
STREET 2: BARTON OAKS PLAZA ONE
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
doc1.xml
FORM 4
X0306
4
2018-07-13
0
0001636282
Aeglea BioTherapeutics, Inc.
AGLE
0001247681
LAWLIS V BRYAN
C/O AEGLEA BIOTHERAPEUTICS, INC.
901 S. MOPAC EXPRESSWAY, SUITE 250
AUSTIN
TX
78746
1
0
0
0
Director Stock Option (right to buy)
8.78
2018-07-13
4
A
0
36800
0
A
2028-07-12
Common Stock
36800
36800
D
The stock option vests and becomes exercisable in 36 equal monthly installments beginning on August 13, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
/s/ Charles N. York II, by power of attorney
2018-07-17